Aliskiren/amlodipine/hydrochlorothiazide
Pharmaceutical drug
From Wikipedia, the free encyclopedia
Aliskiren/amlodipine/hydrochlorothiazide, sold under the brand name Amturnide, is a fixed-dose combination medication that is used to treat high blood pressure.[1][2] It contains aliskiren, a renin inhibitor; amlodipine, as the besylate, a calcium channel blocker; and hydrochlorothiazide, a thiazide diuretic.[1] It is taken by mouth.[1]
Trade namesAmturnide
| Combination of | |
|---|---|
| Aliskiren | Renin inhibitor |
| Amlodipine | Calcium channel blocker |
| Hydrochlorothiazide | Diuretic |
| Clinical data | |
| Trade names | Amturnide |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| PubChem CID | |
| KEGG | |
| Chemical and physical data | |
| Formula | C57H86Cl2N8O15S2 |
| Molar mass | 1258.38 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
It was approved for medical use in the United States in December 2010.[1][3][4] Amturnide was withdrawn by Novartis from the US market in 2017.[5]